-
InDex Pharmaceuticals updates the timeline of the phase III study CONCLUDE with cobitolimod
January 27, 2023 Regulatory
-
InDex Pharmaceuticals Holding AB (publ) interim report January – September 2022
November 23, 2022 Regulatory
InDex Pharmaceuticals Holding AB (publ) published its interim report Q3 for January-September 2022 on November 23 2022 at 08:00 a.m. CET.
-
Year-end Report 2022
-
Annual Report 2022
-
Interim Report Q1 2023